Bone marrow aspirate versus platelet-rich fibrin for chronic plantar fasciitis
Official title: Bone Marrow Aspirate Versus Platelet-Rich Fibrin for the Treatment of Plantar Fasciitis - A Double-Blind Randomized Clinical Trial
Run by Federal University of São Paulo · NCT07242729 · Data updated 2026-11-12
This compares injections of your own bone marrow aspirate versus platelet-rich fibrin to see which reduces heel pain and improves foot function in adults with chronic plantar fasciitis.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 72 (estimated) |
| Sponsor | Federal University of São Paulo Academic / other |
| Locations | 1 site (São Paulo) |
| Status | Recruiting |
| Started | February 1, 2025 |
| Main results expected | February 1, 2027 |
| Study ends | February 1, 2028 |
| Registry record updated | November 21, 2025 |
| Trial ID | NCT07242729 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18–75 years old with ultrasound-confirmed chronic plantar fasciitis for more than six months, baseline VAS ≥4, and persistent symptoms despite conservative care are the intended participants.
✕Probably not a fit
Patients with prior surgery on the affected limb, active local infection or ulceration, systemic inflammatory disease, poorly controlled metabolic disorders, or current use of systemic corticosteroids, immunosuppressants, or anticoagulants are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized, double-blind trial compares ultrasound-guided injections of autologous bone marrow aspirate (harvested from the posterior iliac crest) versus platelet-rich fibrin into the plantar fascia of patients with chronic plantar fasciitis. Procedures are performed under sterile conditions with regional tibial nerve anesthesia and ultrasound guidance to precisely target the symptomatic area. Participants are followed for pain (Visual Analog Scale), foot function (Modified AOFAS), and ultrasonographic plantar fascia thickness at multiple time points up to 24 months. Safety and adverse events are recorded throughout the follow-up period.
Why it matters
Potential benefit: If successful, one of these orthobiologic injections could provide longer-lasting pain relief and better foot function for people who have not improved with standard conservative treatments.
How similar studies have gone: Smaller randomized trials and case series of platelet concentrates and bone marrow–derived products have shown promising reductions in pain and improved function, but head-to-head randomized comparisons between BMA and PRF are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults aged 18 to 75 years. * Clinical diagnosis of chronic plantar fasciitis for more than 6 months, confirmed by ultrasonography (increased plantar fascia thickness and hypoechogenicity). * Persistent heel pain refractory to conventional conservative treatment (stretching, orthotics, physical therapy, or corticosteroid injections). * Visual Analog Scale (VAS) pain score ≥ 4 at baseline. * Ability and willingness to comply with study procedures and follow-up assessments. * Signed informed consent. Exclusion Criteria: * Previous foot or ankle surgery on the affected limb. * Acute trauma, infection, or ulceration in the region of the plantar fascia. * Systemic inflammatory diseases (e.g., rheumatoid arthritis, lupus, psoriatic arthritis). * Metabolic or endocrine disorders interfering with healing (e.g., diabetes mellitus with poor glycemic control, thyroid disorders). * Current use of systemic corticosteroids, immunosuppressants, or anticoagulants. * Active neoplasia or hematologic disorders. * Pregnancy or breastfeeding. * Peripheral vascular disease or neuropathy affecting the lower limbs. * Contraindications to local anesthesia or venipuncture.
Where it's running
-
Federal University of São Paulo - Hospital São Paulo
São Paulo, Brazil Recruiting
Study contacts
- Principal investigator: Lucas Fonseca — Federal University of São Paulo
- Study coordinator: Lucas Fonseca, Md
- Email: contato@drlucasfonseca.med.br
- Phone: +5511982148662
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Extracorporeal Shock Wave Therapy With or Without Kinesio Taping for Plantar Fasciitis
This study tests whether adding kinesio taping to shock wave therapy helps reduce pain and improve foot function in people with plantar fasciitis.
-
Transverse Friction Massage vs Instrument-Assisted Soft-Tissue Mobilization for Plantar Fasciitis
This study tests whether transverse friction massage or instrument-assisted soft-tissue mobilization helps people with plantar fasciitis feel better.
-
Ice packs vs cold baths with standard exercise for heel pain from plantar fasciitis
This trial tests whether ice packs or cold baths, when added to a standard exercise plan, better reduce pain for adults with plantar fasciitis.
-
Do Myofascial Release or Instrument-Assisted Soft Tissue Mobilization Help Pregnant Women with Plantar Fasciitis
This study tests whether two manual therapy techniques, MFR and IASTM, can reduce heel pain and improve foot function in pregnant women with plantar fasciitis.
-
Relationship between central sensitization and clinical features in plantar fasciitis
This study tests how brain-sensitivity, pain intensity, and psychological factors relate to ultrasound findings and how patients function with plantar fasciitis.
-
Barefoot Walking vs Standardised Conservative Care for Plantar Fasciopathy
This trial tests whether a barefoot walking program can reduce heel pain and improve foot function in adults with plantar fasciopathy compared with a standard stretching and strengthening program.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.